普通外文研报
Asia Life Insurance: Hong Kong capital controls – risk to new sales, but unlikely back book
研报英文原文证据摘录
Asia Life Insurance: Hong Kong capital controls – risk to new sales, but unlikely back book
Equity Research
18 June 2026
Asia Life Insurance
Hong Kong capital controls – risk
to new sales, but unlikely back
European Insurancebook
NEUTRAL
Capital controls tightening threatens new business growth for North America Insurance/Life
Asia insurers heavily exposed to Hong Kong (~30-40% of POSITIVE
sales, ~20% MCV), but history suggests limited impact on European Insurance Ivan Bokhmat
back books and earnings, implying recent share price +44 (0)20 7773 0417
weakness may overstate the fundamental risk. ivan.bokhmat@barclays.comBarclays, UK
Claudia Gaspari
The following listed companies are not under coverage by Barclays Research: AIA Group Ltd. +44 (0)20 3134 6039
(1299.HK). Information about these companies is being provided for information purposes only claudia.gaspari@barclays.com
and is not an investment recommendation by Barclays Research. Barclays, UK
Domenico TurcoWe believe the tightening of mainland-Hong Kong capital flows represents a risk to top-
+44 (0)20 7773 3505
line growth, although uncertainty remains on the final shape of the regulation. Current domenico.turco@barclays.com
regulation is focused on investment products (securities, futures and funds) – a minimal Barclays, UK
part of insurance product sales at 3% of sums assured and 6% of annual new business,
respectively. Nevertheless, lower cash inflows into Hong Kong may materially limit new North America Insurance/Life
business growth – after 2016/early 2017 regulatory focus, insurance sales in HK only Alex Scott, CFA
returned to growth in 2019. +1 212 526 1561
alex.scott@barclays.com
Impact on the back books and embedded value should remain minimal, however, unless BCI, US
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器